A new study published in the Journal of Clinical Immunology reveals that researchers at Children's Hospital of Wisconsin Research Institute and Medical College of Wisconsin have developed a new treatment for patients with primary immunodeficiency, known as common variable immunodeficiency (CVID), who have a potentially fatal lung disease. Common variable immunodeficiency (CVID) is the most common primary immunodeficiency that requires regular treatment with medication, ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment